Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies. It also provides clinical sperm analysis (CASA) products comprising IVOS II Clinical and CEROS II Clinical, as well as Human Motility II and Dimensions II Strict Morphology software to clinics, hospitals, and laboratories; animal and research CASA systems, and motility software packages; and various sperm analyzer options. In addition, the company offers sperm analysis accessories, such as Accu-beads+ for use in counting procedures in semen analysis; 2X-CEL disposable semen analysis slides; IDENT Stains for determining sperm motility and concentration; VIADENT stain to determine viable sperm count, concentration, and percentage from a motile sample; and MiniTherm Stage Warmer for CASA and manual sperm motility analysis. Further, it offers IMSI-Strict, an automated software solution for live sperm morphology under high magnification; Oosight imaging system for research purposes; and CIVA, a custom software to capture images/video and annotate. The company sells its products to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is based in Beverly, Massachusetts.
Industry, Sector and Symbol
Stock Exchange CVE
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolCVE:HTL
CUSIPN/A
Phone+1-978-9212050
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins10.14%
Return on Equity16.18%
Return on Assets7.73%
Miscellaneous
EmployeesN/A
Outstanding Shares108,761,000
Market CapC$81.79
Hamilton Thorne (CVE:HTL) Frequently Asked Questions
What is Hamilton Thorne's stock symbol?
Hamilton Thorne trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."
How were Hamilton Thorne's earnings last quarter?
Hamilton Thorne Ltd (CVE:HTL) issued its earnings results on Thursday, May, 24th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $8.85 million for the quarter. Hamilton Thorne had a return on equity of 16.18% and a net margin of 10.14%. View Hamilton Thorne's Earnings History.
When is Hamilton Thorne's next earnings date?
What is the consensus analysts' recommendation for Hamilton Thorne?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
Who are some of Hamilton Thorne's key competitors?
Some companies that are related to Hamilton Thorne include REVA Medical (RVA), Medica Group (MGP), Ellex Medical Lasers (ELXMF), Creo Medical Group (CREO), Kromek Group (KMK), Electromed (ELMD), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Protech Home Medical (PHM), MRI Interventions (MRIC), Surgical Innovations Group (SUN), Neuroone Medical Technologies (NMTC), PetVivo (PETV), Avacta Group (AVCT) and Myomo (MYO).
Who are Hamilton Thorne's key executives?
Hamilton Thorne's management team includes the folowing people:
- Ms. Meg Spencer, Co-Founder & Chairman
- Mr. David B. Wolf, Pres, CEO & Director
- Mr. Diarmaid H. Douglas-Hamilton, Co-Founder, Sr. VP of R&D, CTO, Corp. Sec. and Director
- Mr. Michael W. Bruns, VP of Fin. & CFO (Age 61)
- Mr. Keith F. Edwards, Sr. VP & GM
Has Hamilton Thorne been receiving favorable news coverage?
News articles about HTL stock have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Hamilton Thorne earned a news sentiment score of 0.17 on Accern's scale. They also assigned news stories about the company an impact score of 46.44 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of Hamilton Thorne?
Shares of HTL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Hamilton Thorne's stock price today?
One share of HTL stock can currently be purchased for approximately C$0.91.
How big of a company is Hamilton Thorne?
Hamilton Thorne has a market capitalization of C$81.79 million.
How can I contact Hamilton Thorne?
Hamilton Thorne's mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company can be reached via phone at +1-978-9212050.
MarketBeat Community Rating for Hamilton Thorne (CVE HTL)
MarketBeat's community ratings are surveys of what our community members think about Hamilton Thorne and other stocks. Vote "Outperform" if you believe HTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HTL will underperform the S&P 500 over the long term. You may vote once every thirty days.
